Read news on fewer side effects with our app.
Read more in the app
Scientists from Tufts create weight-loss drug dubbed 'next Ozempic' that's twice as effective and has fewer side effects (affects not only GLP-1 and GIP, but also glucagon and peptide YY)
.jpg)